CALISTA THERAPEUTICS
Calista Therapeutics is developing proprietary peptide drugs for Cystic Fibrosis that are 12 months from IND enablement and clinical trials.
CALISTA THERAPEUTICS
Social Links:
Industry:
Health Care
Founded:
2012-01-01
Address:
Lincoln, Rhode Island, United States
Country:
United States
Website Url:
http://www.calistatherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud OpenResty Google Adsense
Investors List
MassChallenge
MassChallenge investment in Grant - Calista Therapeutics
Official Site Inspections
http://www.calistatherapeutics.com
- Host name: 172.67.218.24
- IP address: 172.67.218.24
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Calista Therapeutics"
Calista Therapeutics - Crunchbase Company Profile
Calista Therapeutics is located in Lincoln, Rhode Island, United States. Who invested in Calista Therapeutics? Calista Therapeutics is funded by …See details»
Calista Therapeutics, Inc. - LinkedIn
Calista Therapeutics was founded in 2012 by peptide therapeutic pioneer and biotech entrepreneur, Andrew Mallon, building upon years of research and business experience in discovering and ...See details»
Calista Therapeutics 2025 Company Profile: Valuation, Funding ...
Calista Therapeutics General Information Description. Developer of proprietary peptide drugs intended for cystic fibrosis. The company discovers and develops novel therapeutics that …See details»
Calista Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Calista Therapeutics, Inc. of Lincoln, RI. Get the latest business insights from Dun & Bradstreet.See details»
Award - SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means …See details»
Firm | SBIR
Calista Therapeutics has discovered a novel 'corrector' therapeutic strategy for Cystic Fibrosis that has already proven very effective in cystic fibrosis patient lung tissue. This …See details»
Calista Therapeutics - VentureRadar
Amount: $247,998.00 | Development of a selective PI3K-Akt-activating neurotrophic small molecule drug, MT-002, for the healing of corneal wounds in Neurotrophic Keratitis.See details»
Calista Therapeutics Inc - Company Profile and News
Calista Therapeutics, Inc. was founded in 2012. The company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or ...See details»
www.calistatherapeutics.com
Www.calistatherapeutics.comSee details»
Calista Therapeutics - Funding, Financials, Valuation & Investors
Nov 1, 2013 Calista Therapeutics is developing proprietary peptide drugs for Cystic Fibrosis that are 12 months from IND enablement and clinical trials. New. Resources. ... How much funding …See details»
Calista Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Calista Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:AT-110, AT-510, AT-0011, AT-210, AT-010. ... The statistics for drugs in the Pipeline is …See details»
CALISTA THERAPEUTICS: Revenue, Worth, Valuation
About CALISTA THERAPEUTICS. CALISTA THERAPEUTICS is a Biotech related company based in Lincoln with 5 employees an estimated revenue of $775K, and. It has 10 competitors …See details»
CALISTA THERAPEUTICS INC | SBIR.gov
DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled …See details»
Calista Therapeutics - Products, Competitors, Financials, …
Calista Therapeutics is a biotechnology company focused on the development of peptide-based therapeutics for various medical conditions. The company specializes in creating medicines …See details»
Calista Therapeutics - VentureRadar
Calista Therapeutics is developing novel treatments for the underlying cause of Cystic Fibrosis, which is achieved by stabilizing the defective ion channel in lung epithelial membranes. …See details»
CALISTA THERAPEUTICS INC Lincoln RI, 02865 - Company Profile
Free Business profile for CALISTA THERAPEUTICS INC at 32 Riverside Dr, Lincoln, RI, 02865-1511, US. CALISTA THERAPEUTICS INC specializes in: Commercial Physical and Biological …See details»
Calista Therapeutics - Overview, News & Similar companies
Calista Therapeutics. Manufacturing · Rhode Island, United States · <25 Employees. View Company Info for Free. About. Headquarters 32 Riverside Dr, Lincoln, Rhode Island, 02865, ...See details»
Calista Therapeutics, Inc. - Lincoln , RI - Company Information
Calista Therapeutics, Inc. C. Calista Therapeutics, Inc. CLAIM THIS BUSINESS. 32 RIVERSIDE DR LINCOLN, RI 02865 Get Directions (401) 345-5979. Business Info. Founded 2012; …See details»
Calista Therapeutics captures SBIR award, awaits word
Sep 30, 2013 PROVIDENCE – Andrew Mallon, CEO of Calista Therapeutics in Lincoln, told ConvergenceRI he was thrilled by the recent Small Business Innovation Research award of …See details»